Recognizing Lean Liver Disease in Clinical Practice Clinicians should consider metabolic liver disease in patients who present with: Normal BMI but central adiposity (increased waist circumference) Mildly elevated liver enzymes without a clear cause Dyslipidemia or insulin resistance features Fatty liver on incidental imaging Routine use of noninvasive tests such as FIB4, ELF score, or transient elastography can help stratify risk and guide hepatology referrals
No Injections Needed
To maintain progress achieved through GLP-1 agonist therapy, continuous dedication to lifestyle interventions is necessary rather than just an initial attempt at improvement
FAQ Allison Buttarazzi, MD Medical Reviewer Allison Buttarazzi, MD, is board-certified in internal medicine and lifestyle medicine, and is a certified health and well-being coach
Protective effects of lycium ruthenicum murray against acute alcoholic liver disease in mice via the nrf2/ho-1/nf-b signaling pathway
With insurance coverage, weight loss drugs can cost as little as $0 to $25, especially if you are eligible for a manufacturer savings program